Advertisement
Corrigendum Free access | 10.1172/JCI63977
Find articles by De Domenico, I. in: JCI | PubMed | Google Scholar
Find articles by Zhang, T. in: JCI | PubMed | Google Scholar
Find articles by Koening, C. in: JCI | PubMed | Google Scholar
Find articles by Branch, R. in: JCI | PubMed | Google Scholar
Find articles by London, N. in: JCI | PubMed | Google Scholar
Find articles by Lo, E. in: JCI | PubMed | Google Scholar
Find articles by Daynes, R. in: JCI | PubMed | Google Scholar
Find articles by Kushner, J. in: JCI | PubMed | Google Scholar
Find articles by Li, D. in: JCI | PubMed | Google Scholar
Find articles by Ward, D. in: JCI | PubMed | Google Scholar
Find articles by Kaplan, J. in: JCI | PubMed | Google Scholar
Published June 1, 2012 - More info
Hepcidin is a peptide hormone that regulates iron homeostasis and acts as an antimicrobial peptide. It is expressed and secreted by a variety of cell types in response to iron loading and inflammation. Hepcidin mediates iron homeostasis by binding to the iron exporter ferroportin, inducing its internalization and degradation via activation of the protein kinase Jak2 and the subsequent phosphorylation of ferroportin. Here we have shown that hepcidin-activated Jak2 also phosphorylates the transcription factor Stat3, resulting in a transcriptional response. Hepcidin treatment of ferroportin-expressing mouse macrophages showed changes in mRNA expression levels of a wide variety of genes. The changes in transcript levels for half of these genes were a direct effect of hepcidin, as shown by cycloheximide insensitivity, and dependent on the presence of Stat3. Hepcidin-mediated transcriptional changes modulated LPS-induced transcription in both cultured macrophages and in vivo mouse models, as demonstrated by suppression of IL-6 and TNF-α transcript and secreted protein. Hepcidin-mediated transcription in mice also suppressed toxicity and morbidity due to single doses of LPS, poly(I:C), and turpentine, which is used to model chronic inflammatory disease. Most notably, we demonstrated that hepcidin pretreatment protected mice from a lethal dose of LPS and that hepcidin-knockout mice could be rescued from LPS toxicity by injection of hepcidin. The results of our study suggest a new function for hepcidin in modulating acute inflammatory responses.
Ivana De Domenico, Tian Y. Zhang, Curry L. Koening, Ryan W. Branch, Nyall London, Eric Lo, Raymond A. Daynes, James P. Kushner, Dean Li, Diane M. Ward, Jerry Kaplan
Original citation: J. Clin. Invest. 2010;120(7): 2395–2405. doi:10.1172/JCI42011.
Citation for this corrigendum: J. Clin. Invest. 2012;122(6):2326. doi:10.1172/JCI63977.
The anti-Fpn and anti-Jak2 rows in Figure 2A were reprinted from I. De Domenico et al. (ref. 10) without attribution. They represent the same rows as were present in Figure 3B of that manuscript.
The authors regret the error.